RecruitingNot ApplicableNCT06296485

Safer Aging With Diabetes Monitoring

Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes

Sponsor

Kaiser Permanente

Enrollment

360 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2 Hypoglycemia

Summary

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Eligibility

Min Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study, called Safer Aging With Diabetes Monitoring, looks at ways to reduce dangerous low blood sugar events in older adults with type 2 diabetes who use insulin. **You may be eligible if...** - You are 75 years of age or older - You have type 2 diabetes and currently use insulin - You have had a low blood sugar episode in the past year, or your records show you are at risk - You can communicate in English - You can access email and the internet **You may NOT be eligible if...** - You are on kidney dialysis - You have dementia - You have a pacemaker or implanted heart defibrillator - You currently use an insulin pump - You have severe mental illness or severe vision impairment - You are in hospice care - You are currently using a continuous glucose monitor (CGM) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.